Photodynamic therapy: superficial and interstitial illumination
- 1 July 2010
- journal article
- research article
- Published by SPIE-Intl Soc Optical Eng in Journal of Biomedical Optics
- Vol. 15 (4), 041502-041502-10
- https://doi.org/10.1117/1.3466579
Abstract
Photodynamic therapy (PDT) is reviewed using the treatment of skin tumors as an example of superficial lesions and prostate cancer as an example of deep-lying lesions requiring interstitial intervention. These two applications are among the most commonly studied in oncological PDT, and illustrate well the different challenges facing the two modalities of PDT—superficial and interstitial. They thus serve as good examples to illustrate the entire field of PDT in oncology. PDT is discussed based on the Lund University group’s over of experience in the field. In particular, the interplay between optical diagnostics and dosimetry and the delivery of the therapeutic light dose are highlighted. An interactive multiple-fiber interstitial procedure to deliver the required therapeutic dose based on the assessment of light fluence rate and sensitizer concentration and oxygen level throughout the tumor is presented.
Keywords
This publication has 59 references indexed in Scilit:
- Treatment planning and dose analysis for interstitial photodynamic therapy of prostate cancerPhysics in Medicine & Biology, 2009
- Hardware acceleration of a Monte Carlo simulation for photodynamic treatment planningJournal of Biomedical Optics, 2009
- Motexafin Lutetium-Photodynamic Therapy of Prostate Cancer: Short- and Long-Term Effects on Prostate-Specific AntigenClinical Cancer Research, 2008
- Optimization of light source parameters in the photodynamic therapy of heterogeneous prostatePhysics in Medicine & Biology, 2008
- Treatment planning using tailored and standard cylindrical light diffusers for photodynamic therapy of the prostatePhysics in Medicine & Biology, 2008
- Preliminary results of interstitial motexafin lutetium‐mediated PDT for prostate cancerLasers in Surgery and Medicine, 2006
- Pretreatment photosensitizer dosimetry reduces variation in tumor responseInternational Journal of Radiation Oncology*Biology*Physics, 2006
- Transperinealin vivofluence-rate dosimetry in the canine prostate during SnET2-mediated PDTPhysics in Medicine & Biology, 2004
- In vivo light dosimetry for motexafin lutetium‐mediated PDT of recurrent breast cancerLasers in Surgery and Medicine, 2002
- Photocytotoxicity in vivo of haematoporphyrin derivative componentsCancer Letters, 1985